Albany, NY -- (SBWIRE) -- 02/22/2017 -- Mammary gland, responsible for lactating is located in the breasts of females. Unlike men, in women, post puberty the glandular tissue develops in response to release of estrogen in females. These glands assist in milk production in lactating mothers post childbirth. Progesterone and prolactin are released during pregnancy, of which progesterone interferes with prolactin and prevents the mammary gland lactation during this period. However, during this period small amounts of pre-milk substance (colostrum) are produced, this substance is rich in nutrients and antibodies that help the infants to sustain for the first few days of life. Post childbirth, the levels of progesterone levels decrease and prolactin levels remain raised which results in milk production or lactation process. The mammary glands are signaled to initiate lactation process after each time a baby is breastfed. During menopausal stage, the tissues become fibrous and degenerative and hence, decrease the capacity of milk production.

Female Mastopathy affects women aged between 17 to 45 years, major complaint being the chest pain resulting from neoplasm. This condition is resultant from misbalance observed in the endocrine profile resulting in improper functioning of mammary glands. Mastopathy has a potential of transformation into cancer, it is a benign neoplasm and not a malignant process. Infrared mammary gland tester, a combination of computer digital technology, imageology and optics is employed in the diagnosis of mastopathy. This device makes use of infrared rays to scan and diagnose breast. The working principle of this device is that, hemoglobin exhibits clear absorption of infrared radiation and hence this light is used to scan the breast tissue. Post the photoelectric conversion by the computer, the signal is processed. Based on the gray image border and distribution of blood vessels it is capable of determining whether the tumor is benign or malignant. In addition, it also identifies the presence of inflammatory proliferative and cystic lesions and has proved to be of high value for filtering the breast cancer cases.

PDF Sample For Latest Innovations And Advancements @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4309

The market for infrared mammary gland testers can be segmented based on the product type and geography. The product type can be further segmented to mobile and stationary products. For instance, Portable Infrared Mammary Gland Tester YKD-1003 and TR5000 Series Infrared Mammary Tester are some of the examples of the mammary gland tester systems. Geographically, North America and Europe are the key revenue contributors to this market. This is attributed to the increased acceptance of novel technologies followed by increasing awareness of breast cancer diagnosis. In addition, factors such increased participation of the market players in developing technologically advanced platforms will further boost the market growth. Asia Pacific and Rest of the World would exhibit positive growth for this market owing to consistent improvement in research and development activities followed by increased government initiatives. In addition, a large patient population coupled with rise in disposable income will favor the market growth in this region. Moreover, factors such as regulatory policies, patient compliance pose a significant impact on the market growth. On the other hand, lack of accessibility and lack of favorable reimbursement policies will further restrain the market growth. Some of the companies operating in this market are Sanwe Group, Ikeda, Beijing Imagetrec, Lianchuang Medical and Yangzhou Fuda Medical Devices Co., Ltd.